Abilev S K, Fonshteĭn L M, Migachev G I, Andrievskiĭ A M
Genetika. 1979;15(5):807-11.
Mutagenic action of 3,7-diamino-4,9-dioxy-5,10-dioxo-4,5,9,10-tetrahydro-4,9-diazapiren (DDDTDP) was shown using indicator strains Salmonella typhimurium TA 1534, TA 1536, TA 1537, TA 1538. The drug-induced mutations in strains TA 1534 and TA 1538, and it can be used as a positive control in testing mutagens capable of inducing frameshift mutations. No significant differences was observed between DDDTDP effects on strains TA 1534 and TA 1538 which did or did not bear rfa mutation causing defects of cell wall lypopolysacharide complex. Within the range of concentrations tested DDDTDP had mutagenic effect without causing essential killing of bacteria. The mutagenic effect was decreased in the in vitro system of metabolic activation (Ames' plate test in Salmonella microsomes).
利用鼠伤寒沙门氏菌TA 1534、TA 1536、TA 1537、TA 1538指示菌株显示了3,7-二氨基-4,9-二氧代-5,10-二氧代-4,5,9,10-四氢-4,9-二氮杂芘(DDDTDP)的诱变作用。该药物在TA 1534和TA 1538菌株中诱导突变,并且它可用作测试能够诱导移码突变的诱变剂的阳性对照。在TA 1534和TA 1538菌株中,无论是否携带导致细胞壁脂多糖复合物缺陷的rfa突变,DDDTDP的作用均未观察到显著差异。在所测试的浓度范围内,DDDTDP具有诱变作用而不会导致细菌大量死亡。在代谢活化的体外系统(沙门氏菌微粒体中的艾姆斯平板试验)中,诱变作用降低。